June 2019 Stock Considerations

After a wild May we seem to be trending back up in June. Of course, anyone in the DGI space already knows that these daily, weekly and monthly swings really don’t matter to anyone with a very long term time horizon. All we can do in the meantime is watch the market swing, stay in the game, find and take advantage of those good deals when they come and enjoy the monthly dividends we receive. Looking at the month of June I am sticking with many of the same potential picks I had back in April and May as prices are still relatively depressed for these stocks. With that being said, let’s take a look at my June stock considerations.

First, I am looking at Altria Group, Inc. (MO). Though the stock has come back quite nicely from its recent lows I still like the stock under $60. The juicy yield well north of 5% is still well covered and the negative sentiment around the stock has not abated which still might give those wishing to go long the stock some time to make up their mind and pick up some shares. I believe MO’s entry into the cannabis and vaping space will, in the long run, pay off as traditional tobacco usage continues to decline.

Another tobacco name I have not looked at in a while is Philip Morris International Inc. (PM). Though the stock has bounced quite nicely from its recent lows about six months ago it is still trading at attractive levels and offering up a juicy yield too.

In the health/biotech space I’m looking to add to my Gilead Sciences, Inc. (GILD). It was one of my potential picks for December and January and was my sole buy in February and as prices continued to remain weak in 2019 and yields, which are still well covered, are around historical highs just below 4%.

Finally, I am looking to buy AbbVie Inc. (ABBV). This was my sole purchase in the month of March and April as I added some shares to my ROTH account. 2019 has been a tough year for the stock and it is once again trading at levels not seen since October of last year. With a sustainable yield pushing well over 5% this long time holding of mine is looking enticing, especially under $80.

A short and sweet list for June. What do you think about my potential stock buys for the month of June? Are you considering any of these names for your own portfolio? Please let me know below.

Disclosure: Long MO, PM, GILD, ABBV

13 thoughts on “June 2019 Stock Considerations

  1. DivHut,

    Some appealing valuations with many of the names listed. Looking forward to seeing which ones you pick up in the coming days and weeks. I am still circling the likes of CAH, CVS, BAYRY, DAL, PSX and DOW and entertaining the thoughts of adding GS and/or MMM to the portfolio.

    Best of luck!
    Passive Income Vortex recently posted…2019 May Dividend SummaryMy Profile

    • Hi PIV,

      I’m still not super hot on CAH. Been holding that for a while now and it really has not performed well. I considered adding to it and average down a bit but as you can see I am looking elsewhere, at least for the month of June. MMM looks like a very popular pick these days.

  2. Another solid list and we have some overlap. Here are two additional stocks I’m looking at… CVS and ADM. I’m close to pulling the buy trigger on CVS. If another pullback happens, it’ll be the newest addition to my dividend income portfolio.

    • Hi FF,

      I like ADM too long term. It’s been in my portfolio for a while now with no intentions to sell. There’s no shortage of names to choose from that offer some tasty yield too.

  3. Hut –

    Excited you have a few different ones you are looking at than me. It’s been hard to find a nice opportunity the last couple of weeks, since we had the immense shock to the system. Going on two weeks and no purchase for me : (

    -Lanny

    • Hi DD,

      Sometimes I go three or four weeks between buys. It happens. Just be patient and that buying opportunity will present itself. I do like LEG as a potential new stock to be added to my portfolio though. Some good picks are still out there.

    • Hi Passivecanadianincome,

      MMM has had a tough 2019, that’s for sure. I know many of our DGI peers have been looking and/or buying in that name as they falter. I like it but am simply looking elsewhere.

    • Hi PC,

      Though ABBV is a large part of my portfolio I still like it under $80 and will consider adding to it. GILD is an interesting biotech play. Similar space to AMGN, another small part of my portfolio.

  4. You have some good choices there. ABBV was a new pick up for me this year and I just received my first dividend from them in May. I have been thinking about adding more to my position. I also own just PM not MO, but I am thinking about adding MO. Other than that, my recent purchase was for MMM which has tumbled quite a bit recently. Thanks, I’ve been a reader for some time now and just wanted to show my support.
    Dividend Savage recently posted…Dividend Update – May 2019My Profile

Leave a Comment

CommentLuv badge

This site uses Akismet to reduce spam. Learn how your comment data is processed.